Related Experiment Video
Updated: Aug 6, 2026

Fully Automated Centrifugal Microfluidic Device for Ultrasensitive Protein Detection from Whole Blood
Published on: April 16, 2016
Structural, microstructural and surface properties of colloidal Pt@TiO₂-rGO nanocomposite for biomedical applications
Omar Gahbiche1, Ridha Ajjel2, Elaa Chiba2
1Laboratory of "Biophysique Métabolique et Toxicologie Professionnelle et Environnementale Appliquée" (LR12ES02), Faculty of Medicine, University of Sousse, Sousse 4002, Tunisia; Centre médical Ibn Khaldoun, Avenue de la liberté 4011 Hammam Sousse, Sousse, Tunisia.
A novel platinum-titanium dioxide-reduced graphene oxide (Pt@TiO₂-rGO) nanocomposite shows promise for multimodal cancer therapy. This material combines sonodynamic therapy, thermal effects, radiotherapy enhancement, and nanozyme activity for potential clinical applications.
Area of Science:
- Materials Science
- Nanotechnology
- Biomedical Engineering
Background:
- Developing multifunctional nanomaterials is crucial for advanced biomedical applications, particularly in cancer therapy.
- Combining multiple therapeutic modalities into a single platform can enhance treatment efficacy and overcome resistance.
- Platinum-based nanocomposites offer unique properties for therapeutic interventions.
Purpose of the Study:
- To synthesize and characterize a multifunctional Pt@TiO₂-rGO nanocomposite.
- To evaluate its potential for ultrasound-activated sonodynamic therapy (SDT), sono-thermal effects, radiotherapy dose enhancement, and nanozyme activity.
- To assess its suitability for biomedical applications, including multimodal cancer therapy.
Main Methods:
- One-step solvothermal synthesis of Pt@TiO₂-rGO nanocomposite.
- PEGylation to improve colloidal stability.
- Evaluation of sonocatalytic activity (methylene blue degradation), sono-thermal effects (temperature increase), radiotherapy dose enhancement, and enzyme-mimetic activity (peroxidase and catalase).
Main Results:
- High sonocatalytic activity (85% methylene blue degradation in 30 min) mediated by reactive oxygen species (ROS).
- Significant temperature increase (up to 52.3°C) under ultrasound irradiation for thermal therapy.
- Radiotherapy dose enhancement of approximately 11.62% under electron irradiation, suitable for superficial treatments.
- Demonstrated peroxidase-like and catalase-like activities, functioning as a nanozyme.
Conclusions:
- The Pt@TiO₂-rGO nanocomposite is a versatile platform integrating SDT, thermal therapy, radiotherapy enhancement, and catalytic functions.
- This multifunctional material shows significant potential for multimodal cancer therapy.
- Further in vivo and biological studies are necessary to confirm its clinical applicability.